Phenytoin-induced hyperglycaemia may confound rat cerebroprotection models.
1. The anticonvulsant phenytoin (PHT) has been used with variable success in animal models of cerebral ischaemia. Although PHT has been reported to alter glucose regulation in man, this potential effect has been largely ignored in animals. Because hyperglycaemia strongly influences the outcome of cerebral ischaemia, we sought to systematically delineate the effects of PHT on serum glucose in several rat strains. 2. We studied the PHT dose-response curve for serum PHT and glucose concentrations and several physiological variables. Phenytoin induces a significant, concentration-dependent hyperglycaemia, even in the ranges commonly used for humans and in animal models. 3. Hypothermia of several degrees was observed during PHT administration, but no hypotension or bradycardia was found. 4. Both hyperglycaemia and hypothermia must be considered when PHT is studied as a neuroprotective agent in animal models.
Qi
H
H
Department of Neurology, State University of New York, Stony Brook 11794-8121, USA.
Newman
G C
GC
D000818:Animals; D000927:Anticonvulsants / Q000097:blood / Q000494:pharmacology / Q000633:toxicity*; D001522:Behavior, Animal / Q000187:drug effects; D001786:Blood Glucose / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D006801:Humans; D006943:Hyperglycemia / Q000097:blood / Q000139:chemically induced*; D008297:Male; D018696:Neuroprotective Agents / Q000097:blood / Q000494:pharmacology / Q000633:toxicity*; D010672:Phenytoin / Q000031:analogs & derivatives / Q000097:blood / Q000494:pharmacology / Q000633:toxicity*; D011355:Prodrugs / Q000378:metabolism / Q000494:pharmacology / Q000633:toxicity; D051381:Rats; D011916:Rats, Inbred F344; D011921:Rats, Inbred WKY; D017207:Rats, Sprague-Dawley
D000927:Anticonvulsants; D001786:Blood Glucose; D018696:Neuroprotective Agents; D011355:Prodrugs; D010672:Phenytoin; C043114:fosphenytoin